Robert C. Faulkner Augmedix, Inc. (AUGX) insider trading activity

Robert C. Faulkner is Director of Augmedix, Inc.. Currently has a direct ownership of 0 shares of AUGX, which is worth approximately $0. The most recent transaction as insider was on Oct 02, 2024, when has been sold 41,461 shares (Common Stock) at a price of $2.35 per share, resulting in proceeds of $97,433. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Robert C. Faulkner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 02 2024	BUY Sale (or disposition) back to the issuer	$97,433 $2.35 p/Share	41,461 Added 100.0%	0 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	12,879 Added 23.7%	41,461 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	3,125 Added 9.86%	28,582 Common Stock
Dec 15 2023	BUY Grant, award, or other acquisition	-	1,767 Added 6.49%	25,457 Common Stock
Aug 31 2023	BUY Grant, award, or other acquisition	$9,999 $4.78 p/Share	2,092 Added 8.11%	23,690 Common Stock
Jul 13 2023	BUY Grant, award, or other acquisition	-	21,598 Added 50.0%	21,598 Common Stock

Also insider at

SNCE

Science 37 Holdings, Inc. Healthcare

MDVL

MedAvail Holdings, Inc. Healthcare

Director

RCF